Evidence map›Paper›PMID 37709822›Full record

ArticleNature cell biology2023

DMRT1 regulates human germline commitment.

Naoko Irie, Sun-Min Lee, Valentina Lorenzi, Haiqi Xu, Jinfeng Chen, Masato Inoue, Toshihiro Kobayashi, Carmen Sancho-Serra, Elena Drousioti, Sabine Dietmann and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Overlapping genetic etiology of pediatric and adult germ cell tumors.Journal of the National Cancer Institute · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 4 countries.

Naoko Irie *Wellcome Trust/Cancer Research UK Gurdon Institute, Henry Wellcome Building of Cancer and Developmental Biology, Cambridge, UK. irienaoko@ciea.or.jp.ORCID http://orcid.org/0000-0001-7333-1802
Sun-Min Lee *Wellcome Trust/Cancer Research UK Gurdon Institute, Henry Wellcome Building of Cancer and Developmental Biology, Cambridge, UK.
Valentina LorenziWellcome Sanger Institute, Cambridge, UK.ORCID http://orcid.org/0000-0002-3111-4006
Haiqi XuLudwig Institute for Cancer Research and Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jinfeng ChenLudwig Institute for Cancer Research and Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Masato InoueLudwig Institute for Cancer Research and Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Toshihiro KobayashiDivision of Mammalian Embryology, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Carmen Sancho-SerraWellcome Sanger Institute, Cambridge, UK.
Elena DrousiotiWellcome Trust/Cancer Research UK Gurdon Institute, Henry Wellcome Building of Cancer and Developmental Biology, Cambridge, UK.
Sabine DietmannDepartment of Developmental Biology and Institute for Informatics, Washington University School of Medicine, St. Louis, MO, USA.
Roser Vento-TormoWellcome Sanger Institute, Cambridge, UK.ORCID http://orcid.org/0000-0002-9870-8474
Chun-Xiao SongLudwig Institute for Cancer Research and Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-7781-6521
M Azim SuraniWellcome Trust/Cancer Research UK Gurdon Institute, Henry Wellcome Building of Cancer and Developmental Biology, Cambridge, UK. a.surani@gurdon.cam.ac.uk.ORCID http://orcid.org/0000-0002-8640-4318
Ludwig Cancer Research · GBWellcome Sanger Institute · GBCentral Institute for Experimental Animals · JPEuropean Bioinformatics Institute · GBKonkuk University · KRNational Institute for Physiological Sciences · JPThe Gurdon Institute · GBUniversity of Cambridge · GBWashington University in St. Louis · US

Funding

Biotechnology and Biological Sciences Research Council BB/T01346X/1Biotechnology and Biological Sciences Research Council G103986Cancer Research UK 26394Cancer Research UK 27122Cancer Research UK C63763/A26394Cancer Research UK C63763/A27122Department of HealthMedical Research Council RG85305Wellcome Trust 209475/Z/17/Z
6 · The paper itself

Abstract

Germline commitment following primordial germ cell (PGC) specification during early human development establishes an epigenetic programme and competence for gametogenesis. Here we follow the progression of nascent PGC-like cells derived from human embryonic stem cells in vitro. We show that switching from BMP signalling for PGC specification to Activin A and retinoic acid resulted in DMRT1 and CDH5 expression, the indicators of migratory PGCs in vivo. Moreover, the induction of DMRT1 and SOX17 in PGC-like cells promoted epigenetic resetting with striking global enrichment of 5-hydroxymethylcytosine and locus-specific loss of 5-methylcytosine at DMRT1 binding sites and the expression of DAZL representing DNA methylation-sensitive genes, a hallmark of the germline commitment programme. We provide insight into the unique role of DMRT1 in germline development for advances in human germ cell biology and in vitro gametogenesis.

Indexed as

DNA MethylationHuman Embryonic Stem CellsCell DifferentiationGerm CellsHumansSignal TransductionTranscription FactorsDMRT1 proteinTranscription Factors

Identifiers

PMID37709822
PMCPMC10567552
OpenAlexW4386741316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.